Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Potential therapeutic targets for growth arrest of colorectal cancer cells exposed to PTHrP.

Martín MJ, Gigola G, Zwenger A, Carriquiriborde M, Gentil F, Gentili C.

Mol Cell Endocrinol. 2018 Jul 21. pii: S0303-7207(18)30221-1. doi: 10.1016/j.mce.2018.07.005. [Epub ahead of print]

PMID:
30009852
2.

Chilean Gastric Cancer Task Force: A study protocol to obtain a clinical and molecular classification of a cohort of gastric cancer patients.

Owen GI, Pinto MP, Retamal IN, Fernádez MF, Cisternas B, Mondaca S, Sanchez C, Galindo H, Nervi B, Ibañez C, Acevedo F, Madrid J, Peña J, Bravo ML, Maturana MJ, Cordova-Delgado M, Romero D, de la Jara N, Torres J, Rodriguez-Fernandez M, Espinoza M, Balmaceda C, Freire M, Gárate-Calderón V, Crovari F, Jimenez-Fonseca P, Carmona-Bayonas A, Zwenger A, Armisen R, Corvalan AH, Garrido M.

Medicine (Baltimore). 2018 Apr;97(16):e0419. doi: 10.1097/MD.0000000000010419.

3.

Reduction of SR Ca2+ leak and arrhythmogenic cellular correlates by SMP-114, a novel CaMKII inhibitor with oral bioavailability.

Neef S, Mann C, Zwenger A, Dybkova N, Maier LS.

Basic Res Cardiol. 2017 Jul;112(4):45. doi: 10.1007/s00395-017-0637-y. Epub 2017 Jun 13.

PMID:
28612156
4.

Prognostic factors and survival according to tumour subtype in women presenting with breast cancer brain metastases at initial diagnosis.

Leone JP, Leone J, Zwenger AO, Iturbe J, Leone BA, Vallejo CT.

Eur J Cancer. 2017 Mar;74:17-25. doi: 10.1016/j.ejca.2016.12.015. Epub 2017 Feb 6.

PMID:
28335884
5.

Locoregional treatment and overall survival of men with T1a,b,cN0M0 breast cancer: A population-based study.

Leone JP, Leone J, Zwenger AO, Iturbe J, Leone BA, Vallejo CT.

Eur J Cancer. 2017 Jan;71:7-14. doi: 10.1016/j.ejca.2016.10.038. Epub 2016 Dec 8.

PMID:
27940356
6.

Role of difucosylated Lewis Y antigen in outcome of locally advanced cervical squamous cell carcinoma treated with cisplatin regimen.

Leone J, Perez JE, Dominguez ME, Iturbe J, Leone JP, Mac Donnell MC, Grosman G, Vallejo CT, Leone BA, Zwenger AO.

Int J Biol Markers. 2016 Jul 30;31(3):e300-8. doi: 10.5301/jbm.5000206.

PMID:
27197582
7.

Prognostic factors in male breast cancer: a population-based study.

Leone JP, Zwenger AO, Iturbe J, Leone J, Leone BA, Vallejo CT, Bhargava R.

Breast Cancer Res Treat. 2016 Apr;156(3):539-548. doi: 10.1007/s10549-016-3768-1. Epub 2016 Apr 2.

PMID:
27039306
8.

From Molecular Biology to Clinical Trials: Toward Personalized Colorectal Cancer Therapy.

Palma S, Zwenger AO, Croce MV, Abba MC, Lacunza E.

Clin Colorectal Cancer. 2016 Jun;15(2):104-15. doi: 10.1016/j.clcc.2015.11.001. Epub 2015 Dec 2. Review.

PMID:
26777471
9.

Expression of ERCC1 and TUBB3 in locally advanced cervical squamous cell cancer and its correlation with different therapeutic regimens.

Zwenger AO, Grosman G, Iturbe J, Leone J, Vallejo CT, Leone JP, Verdera PP, Pérez JE, Leone BA.

Int J Biol Markers. 2015 Jul 22;30(3):e301-14. doi: 10.5301/jbm.5000161.

PMID:
26165688
10.

Prognostic significance of tumor subtypes in male breast cancer: a population-based study.

Leone JP, Leone J, Zwenger AO, Iturbe J, Vallejo CT, Leone BA.

Breast Cancer Res Treat. 2015 Aug;152(3):601-9. doi: 10.1007/s10549-015-3488-y. Epub 2015 Jul 1.

PMID:
26126972
11.

High expression of sLex associated with poor survival in Argentinian colorectal cancer patients.

Zwenger A, Rabassa M, Demichelis S, Grossman G, Segal-Eiras A, Croce MV.

Int J Biol Markers. 2014 Mar 24;29(1):e30-9. doi: 10.5301/jbm.5000060.

PMID:
24425323
12.

Sixteen years follow-up results of a randomized phase II trial of neoadjuvant fluorouracil, doxorubicin, and cyclophosphamide (FAC) compared with cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in stage III breast cancer: GOCS experience.

Leone JP, Leone J, Vallejo CT, Pérez JE, Romero AO, Machiavelli MR, Romero Acuña L, Domínguez ME, Langui M, Fasce HM, Leone BA, Ortiz E, Iturbe J, Zwenger AO.

Breast Cancer Res Treat. 2014 Jan;143(2):313-23. doi: 10.1007/s10549-013-2806-5. Epub 2013 Dec 11.

PMID:
24327333
13.

RHBDD2: a 5-fluorouracil responsive gene overexpressed in the advanced stages of colorectal cancer.

Lacunza E, Canzoneri R, Rabassa ME, Zwenger A, Segal-Eiras A, Croce MV, Abba MC.

Tumour Biol. 2012 Dec;33(6):2393-9. doi: 10.1007/s13277-012-0503-3. Epub 2012 Sep 11.

PMID:
22965880
14.

Treatment of early breast cancer, a long-term follow-up study: the GOCS experience.

Iturbe J, Zwenger A, Leone JP, Verdera PP, Vallejo C, Romero A, Perez J, Machiavelli M, Leone B.

Breast J. 2011 Nov-Dec;17(6):630-7. doi: 10.1111/j.1524-4741.2011.01157.x.

PMID:
22050282

Supplemental Content

Loading ...
Support Center